Laboratory analysis reveals the biophysical properties and infectivity of cocoa necrosis virus in plant hosts, indicating it represents a distinct serotype of tomato black ring virus.
SUMMARY Cocoa necrosis virus (CNV) was transmitted by sap inoculation to twelve of twenty‐one species tested. It was propagated and assayed in Phaseolus vulgaris. Sap from P. vulgaris was infective after dilution to 10‐3but not 10‐4, after 10 min at 60 d̀C but not 65 d̀C, and after 4 but not 7 days at 20–24 d̀C. Lyophilized sap from P. vulgaris was infective after 2 years in vacuo. Virus was prepared by extracting infected leaves of P. vulgaris with 0.1 M phosphate (pH 7.5) containing 0.05 M ethylene diamine tetra‐acetate and 0.02 M thioglycollate. After clarification with n‐butanol, virus was purified by precipitation with polyethylene glycol and several cycles of differential centrifugation. Such preparations were very infective and contained numerous particles, 24–26 nm in diameter with a hexagonal profile, which sedimented as two components with sedimentation coefficients (Sd̀20,w) of 101 S and 129 S. The absorption spectra of both components with maximum and minimum absorption at 259 and 240 nm respectively were typical of nucleoproteins (101 S component, A 260/280 = 1.63; A 260/240 = 1.40:129 S component, A260/280 = 1.78; A260/240 = 1.58) and indicated nucleic acid contents of ca. 35% for the 129 S component and ca. 20% for the 101 S component; values calculated from the sedimentation coefficients were 41 and 30% respectively. Only the 129 S component seemed to be infective and was not more so when mixed with 101 S component. Both components contained a single protein subunit weighing ca. 60000 daltons. Under certain conditions sap fractionated without butanol gave virus preparations containing empty protein shells (54 S) and small spherical particles (20–30 S) ca. 12 nm diameter. CNV is a serotype of tomato blackring virus and is distantly related to Hungarian chrome mosaic virus. The cryptogram of CNV is */*:*/(35–41):S/S:S/*.
No takes yet. Share an insight, caveat, or question.
R. H. Kenten (1972) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: